Statistics
Publications
34
Citations
1.2K
H-Index
23
Active since
2008
Xiaoling Du is an author at Nankai University specializing in medicine, oncology, and steroid hormone signaling.
Publications per year
2008–2024
34
34
Advances in targeted therapy for osteosarcoma.
Mengze Hao, Xiaoling Du, Guowen Wang et al. · PubMed · 2014 · 135 citations
Medicine, Cancer Biology, Oncology +17
Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China
Feng Li, Zhichao Liao, Jun Zhao et al. · Oncotarget · 2017 · 59 citations · Full text
Medicine, Oncology, Pharmacology +15
The genetic basis for inactivation of Wnt pathway in human osteosarcoma
Xiaoling Du, Jilong Yang, Da Yang et al. · BMC Cancer · 2014 · 58 citations · Full text
Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma
Jilong Yang, David Cogdell, Da Yang et al. · Cancer Letters · 2009 · 57 citations
1–5 of 34